Ronald Balkissoon is a Respiratory physician affiliated with National Jewish Health. OpenAlex indexes 36 publications with 1,394 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 Jackson St
Denver, CO 802062761
Telephone
303-388-4461Provider last certified this registry record 12 Nov 2020.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year202555 payments$64,448openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202529 payments$36,115openpaymentsdata.cms.gov ↗
- Genentech USA, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
40.2%H2 blocker21.3%Famotidine100%Part D≥54 patientsProton pump inhibitor18.9%Pantoprazole Sodium60%Omeprazole24%Esomeprazole Magnesium16%Part D<11 patientsMusculoskeletal
23.3%gamma-Aminobutyric Acid-ergic Agonist23.3%Baclofen100%Part D≥57 patientsRespiratory
22.5%Corticosteroid15.2%Trelegy Ellipta40%Fluticasone Propionate35%Breztri Aerosphere25%Part D<11 patientsHistamine-1 Receptor Antagonist7.3%Azelastine Hcl100%Part D≥28 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US
Journal of Asthma and Allergy
2023 - Optimizing asthma management: Role of long-acting muscarinic antagonists
Journal of Allergy and Clinical Immunology
2022 - The Use of Inhaled Corticosteroids for Patients with COPD Who Continue to Smoke Cigarettes: An Evaluation of Current Practice
The American Journal of Medicine
2021 - Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure
The Journal of Allergy and Clinical Immunology In Practice
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Donald Leung, MD
National Jewish Health
James Crapo, MD
National Jewish Health
Barry Make, MD
National Jewish Health
Charles Daley, MD
National Jewish Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”